Fast-Acting Antimicrobials

  • Author:
  • Published: 21 February 2016
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Small/Wiley-VCH
thumbnail image: Fast-Acting Antimicrobials

In the fight against drug-resistant pathogens, new antibiotics and antimicrobials are urgently needed. Antimicrobial peptides (AMPs) have been considered as an alternative to traditional antibiotics. They kill bacteria by disrupting their cell membrane. However, they are expensive to manufacture and have insufficient stability in vivo. AMP mimics which consist of synthetic polymers or oligomers could solve these problems.

Haibin Su, Nanyang Technological University, Singapore, Yugen Zhang, Institute of Bioengineering and Nanotechnology, Singapore, and colleagues have developed imidazolium oligomers with terminal alkyl groups (pictured below) which kill bacteria using this approach. The team tested their performance against the pathogens Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans and compared it to antibiotics that are commonly used against these microbes, such as vancomycin. The oligomers showed comparable or better performance in killing the bacteria.


Fast-Acting Antimicrobials


The selectivity of the oligomers for bacterial over mammalian cells was tested by measuring their propensity to induce hemolysis. The compounds with shorter aliphatic sidechains up to C10 showed selectivity indices in a safe range. The oligomers are fast-acting, and kill 99.9 % of the pathogens within two minutes. Previously reported antimicrobials such as AMPs and silver nanoparticles do this on a time scale of minutes to hours.

According to the researchers, the properties of these imidazolium materials suggest potential for their use as an antimicrobial agent, particularly in sterilization and other health care applications.


Article Views: 3331

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in


shailendrakumar bhandari wrote:

Promising research in pharma-related synthetic organic chemistry

Seems to be promising research in pharma-related synthetic organic chemistry. May open new commercial drug class.

Thu Mar 03 00:08:04 UTC 2016

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH